Literature DB >> 7304894

High dose buprenorphine for postoperative analgesia.

K Budd.   

Abstract

Buprenorphine was given intravenously to produce analgesia in the immediate postoperative period, the dose being titrated against the response of each patient in order to obtain complete freedom from pain. In 50 patients following lower segment Caesarean section under general anaesthesia, buprenorphine in the dose range 0.4-7.0 mg was found to be a potent, long lasting and safe analgesic. Serial blood gas estimations performed on ten of the patients confirmed the clinically observed lack of respiratory depression.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7304894     DOI: 10.1111/j.1365-2044.1981.tb08867.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  13 in total

1.  [Not Available].

Authors:  M Zenz
Journal:  Schmerz       Date:  1987-07       Impact factor: 1.107

Review 2.  Clinical pharmacokinetics of narcotic agonist-antagonist drugs.

Authors:  R E Bullingham; H J McQuay; R A Moore
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

Review 3.  Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option.

Authors:  Mellar P Davis; Gavril Pasternak; Bertrand Behm
Journal:  Drugs       Date:  2018-08       Impact factor: 9.546

4.  Imaging drugs with and without clinical analgesic efficacy.

Authors:  Jaymin Upadhyay; Julie Anderson; Adam J Schwarz; Alexandre Coimbra; Richard Baumgartner; G Pendse; Edward George; Lauren Nutile; Diana Wallin; James Bishop; Saujanya Neni; Gary Maier; Smriti Iyengar; Jeffery L Evelhoch; David Bleakman; Richard Hargreaves; Lino Becerra; David Borsook
Journal:  Neuropsychopharmacology       Date:  2011-08-17       Impact factor: 7.853

Review 5.  Current developments in intraspinal agents for cancer and noncancer pain.

Authors:  Erin F Lawson; Mark S Wallace
Journal:  Curr Pain Headache Rep       Date:  2010-02

Review 6.  Transdermal buprenorphine.

Authors:  Hannah C Evans; Stephanie E Easthope
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine.

Authors:  Zhe Ding; Robert B Raffa
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

8.  Which potent opioid? Important criteria for selection.

Authors:  J G Bovill
Journal:  Drugs       Date:  1987-05       Impact factor: 9.546

9.  Transdermal buprenorphine - a critical appraisal of its role in pain management.

Authors:  Guy Hans; Dominique Robert
Journal:  J Pain Res       Date:  2009-09-15       Impact factor: 3.133

10.  The perioperative patient on buprenorphine: a systematic review of perioperative management strategies and patient outcomes.

Authors:  Akash Goel; Saam Azargive; Wiplove Lamba; Joel Bordman; Marina Englesakis; Sanjho Srikandarajah; Karim Ladha; Tania Di Renna; Harsha Shanthanna; Scott Duggan; Philip Peng; John Hanlon; Hance Clarke
Journal:  Can J Anaesth       Date:  2018-11-27       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.